637 related articles for article (PubMed ID: 25591863)
1. Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.
Olivier AK; Gibson-Corley KN; Meyerholz DK
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G459-71. PubMed ID: 25591863
[TBL] [Abstract][Full Text] [Related]
2. Hepatobiliary complications of cystic fibrosis.
Feranchak AP
Curr Gastroenterol Rep; 2004 Jun; 6(3):231-9. PubMed ID: 15128491
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis.
Sathe MN; Freeman AJ
Pediatr Clin North Am; 2016 Aug; 63(4):679-98. PubMed ID: 27469182
[TBL] [Abstract][Full Text] [Related]
4. Intestinal complications of cystic fibrosis.
Borowitz D; Gelfond D
Curr Opin Pulm Med; 2013 Nov; 19(6):676-80. PubMed ID: 24060981
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis.
Modolell I; Alvarez A; Guarner L; De Gracia J; Malagelada JR
Pancreas; 2001 May; 22(4):395-9. PubMed ID: 11345141
[TBL] [Abstract][Full Text] [Related]
6. Management of pancreatic, gastrointestinal and liver complications in adult cystic fibrosis.
Munck A; Languepin J; Debray D; Lamireau T; Abely M; Huet F; Maudinas R; Michaud L; Mas E
Rev Mal Respir; 2015 Jun; 32(6):566-85. PubMed ID: 26001957
[TBL] [Abstract][Full Text] [Related]
7. The porcine lung as a potential model for cystic fibrosis.
Rogers CS; Abraham WM; Brogden KA; Engelhardt JF; Fisher JT; McCray PB; McLennan G; Meyerholz DK; Namati E; Ostedgaard LS; Prather RS; Sabater JR; Stoltz DA; Zabner J; Welsh MJ
Am J Physiol Lung Cell Mol Physiol; 2008 Aug; 295(2):L240-63. PubMed ID: 18487356
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study.
Soave D; Miller MR; Keenan K; Li W; Gong J; Ip W; Accurso F; Sun L; Rommens JM; Sontag M; Durie PR; Strug LJ
Diabetes; 2014 Jun; 63(6):2114-9. PubMed ID: 24550193
[TBL] [Abstract][Full Text] [Related]
9. Loss of cftr function leads to pancreatic destruction in larval zebrafish.
Navis A; Bagnat M
Dev Biol; 2015 Mar; 399(2):237-48. PubMed ID: 25592226
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal pathophysiology and nutrition in cystic fibrosis.
Ratchford TL; Teckman JH; Patel DR
Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):853-862. PubMed ID: 30019967
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
Salvatore F; Scudiero O; Castaldo G
Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis-associated liver disease.
Herrmann U; Dockter G; Lammert F
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):585-92. PubMed ID: 20955961
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal manifestations of cystic fibrosis: a review.
Park RW; Grand RJ
Gastroenterology; 1981 Dec; 81(6):1143-61. PubMed ID: 7026347
[No Abstract] [Full Text] [Related]
14. A sheep model of cystic fibrosis generated by CRISPR/Cas9 disruption of the CFTR gene.
Fan Z; Perisse IV; Cotton CU; Regouski M; Meng Q; Domb C; Van Wettere AJ; Wang Z; Harris A; White KL; Polejaeva IA
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282831
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.
Ooi CY; Durie PR
J Cyst Fibros; 2012 Sep; 11(5):355-62. PubMed ID: 22658665
[TBL] [Abstract][Full Text] [Related]
16. Defective CFTR promotes intestinal proliferation via inhibition of the hedgehog pathway during cystic fibrosis.
Liu K; Wang X; Zou C; Zhang J; Chen H; Tsang L; Yu MK; Chung YW; Wang J; Dai Y; Liu Y; Zhang X
Cancer Lett; 2019 Apr; 446():15-24. PubMed ID: 30639531
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy.
McDonald CM; Reid EK; Pohl JF; Yuzyuk TK; Padula LM; Vavrina K; Altman K
Nutr Clin Pract; 2024 Apr; 39 Suppl 1():S57-S77. PubMed ID: 38429959
[TBL] [Abstract][Full Text] [Related]
18. Cholangiocyte biology and cystic fibrosis liver disease.
Feranchak AP; Sokol RJ
Semin Liver Dis; 2001 Nov; 21(4):471-88. PubMed ID: 11745036
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary disease in cystic fibrosis patients with pancreatic sufficiency.
Waters DL; Dorney SF; Gruca MA; Martin HC; Howman-Giles R; Kan AE; De Silva M; Gaskin KJ
Hepatology; 1995 Apr; 21(4):963-9. PubMed ID: 7535738
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic pathophysiology in cystic fibrosis.
Gibson-Corley KN; Meyerholz DK; Engelhardt JF
J Pathol; 2016 Jan; 238(2):311-20. PubMed ID: 26365583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
